Nonsense Code News Today : Breaking News, Live Updates & Top Stories | Vimarsana

And this is just the next step. the us drug company is seeking emergency approval for the drug, which us authorities say is no substitute for preventative vaccines. but this is an exciting development, as the first company to report trial results of a pill to treat covid as other companies also work on similar treatments. mark lobel, bbc news. earlier i spoke to epidemiologist and health economist dr eric feigl—ding, and asked him how much of a game changer this new drug is in the fight against covid. this pill is quite remarkable. it is not based on any spike proteins like the vaccines are,...

Preventative vaccines. but this is an exciting development, as the first company to report trial results of a pill to treat covid as other companies also work on similar treatments. mark lobel, bbc news. well, let's speak now to epidemiologist and health economist doctor eric fogel ding, whojoins us from washington. —— feigl—ding. doctor feigl—ding, thank you forjoining us. took us three how this pill works? this pill is quite remarkable. it is not based on any spiked proteins like the vaccines are, it is agnostic to variants, because it targets the molecular machinery of the virus. it...

Authorities say is no substitute for preventative vaccines. but this is an exciting development, as the first company to report trial results of a pill to treat covid as other companies also work on similar treatments. mark lobel, bbc news. well, earlier i spoke to epidemiologist and health economist dr eric feigl—ding, and ask them how much of a game changer this new drug was in the fight against covid. this pill is quite remarkable. it is not based on any spike proteins like the vaccines are, it is agnostic to variants, because it targets the molecular machinery of the virus. it adds lots ...

And this is just the next step. the us drug company is seeking emergency approval for the drug, which us authorities say is no substitute for preventative vaccines. but this is an exciting development, as the first company to report trial results of a pill to treat covid as other companies also work on similar treatments. mark lobel, bbc news. earlier i spoke to epidemiologist and health economist dr eric feigl—ding, and asked him how much of a game changer this new drug is in the fight against covid. this pill is quite remarkable. it is not based on any spike proteins like the vaccines are,...

But this is an exciting development, as the first company to report trial results of a pill to treat covid as other companies also work on similar treatments. mark lobel, bbc news. earlier i spoke to epidemiologist and health economist dr eric feigl—ding, and asked him how much of a game changer this new drug is in the fight against covid. this pill is quite remarkable. it is not based on any spike proteins like the vaccines are, it is agnostic to variants, because it targets the molecular machinery of the virus. it adds lots of nonsense code. it completely corrupts the genome of the virus, ...